Highlights and Quick Summary
- R&D Expenses for the quarter ending September 30, 2022 was $2.97 Million (a -11.63% decrease compared to previous quarter)
- Year-over-year quarterly R&D Expenses increased by 4.14%
- Annual R&D Expenses for 2021 was $12.8 Million (a 18.22% increase from previous year)
- Annual R&D Expenses for 2020 was $10.8 Million (a 3.34% increase from previous year)
- Annual R&D Expenses for 2019 was $10.5 Million (a 27.85% increase from previous year)
- Twelve month R&D Expenses ending September 30, 2022 was $12.4 Million (a -2.54% decrease compared to previous quarter)
- Twelve month trailing R&D Expenses decreased by -3.13% year-over-year
Trailing R&D Expenses for the last four month:
30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
---|---|---|---|
$12.4 Million | $12.7 Million | $12.7 Million | $12.8 Million |
Visit stockrow.com/BDSX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical R&D Expenses of Biodesix, Inc.
Most recent R&D Expensesof BDSX including historical data for past 10 years.Interactive Chart of R&D Expenses of Biodesix, Inc.
Biodesix, Inc. R&D Expenses for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | – | $2.97 | $3.36 | $3.21 | – |
2021 | $2.85 | $3.29 | $3.32 | $3.32 | $12.79 |
2020 | $3.11 | $2.71 | $2.11 | $2.9 | $10.82 |
2019 | – | – | $2.5 | $2.36 | $10.47 |
2018 | – | – | – | – | $8.19 |
Business Profile of Biodesix, Inc.
Sector: Healthcare
Industry: Diagnostics & Research